Cleared Traditional

GREEN LABEL BIOBRANE II AND RED LABEL BIOBRANE II (K901369) - FDA 510(k) Clearance

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1990
Decision
74d
Days
-
Risk

K901369 is an FDA 510(k) clearance for the GREEN LABEL BIOBRANE II AND RED LABEL BIOBRANE II. Classified as Wound Dressing With Animal-derived Material(s) (product code KGN).

Submitted by Sterling Drug, Inc. (New York, US). The FDA issued a Cleared decision on June 5, 1990 after a review of 74 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Sterling Drug, Inc. devices

Submission Details

510(k) Number K901369 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 23, 1990
Decision Date June 05, 1990
Days to Decision 74 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
41d faster than avg
Panel avg: 115d · This submission: 74d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code KGN Wound Dressing With Animal-derived Material(s)
Device Class -

Regulatory Peers - KGN Wound Dressing With Animal-derived Material(s)

All 186
Devices cleared under the same product code (KGN) and FDA review panel - the closest regulatory comparables to K901369.
Catalyze
K253204 · BioTissue Holdings, Inc. · Jun 2026
Roosin Collagen Dressing
K253974 · Roosin Medical Co., Ltd. · Jun 2026
Roosin Collagen Powder
K254034 · Roosin Medical Co., Ltd. · Jun 2026
MatriDerm
K261224 · Medskin Solutions Dr. Suwelack AG · May 2026
Derma-Gide
K260532 · Geistlich Pharma AG · Mar 2026
LacertaMatrix
K260218 · Lacerta Life Sciences · Feb 2026